NVCT
Nuvectis Pharma, Inc.−0.84 (−4.33%) TodayNov 4, 10:43 AM ET
About NVCT
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Company
- Headquarters
- Fort Lee, NJ
- Employees
- 13 (2026)
- Listed
- Feb 4, 2022
- Exchange
- Nasdaq
- Website
- nuvectis.com
- SEC industry
- Pharmaceutical Preparations
- Cylvex sector
- Health Care · Pharmaceuticals
Pharmaceuticals
- Market cap #158 of 430
- P/B #11 of 396
Ranked highest first among stocks Cylvex covers.
- LLYEli Lilly and Company$1.26T+0.59%
- JNJJohnson & Johnson$651.4B+1.66%
- ABBVAbbVie Inc$504.3B-0.21%
- MRKMerck & Co Inc$363.7B+1.90%
- NVSNovartis AG$307.7B+2.29%
Financial summary
Related companies
About
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
From company filings and market data · Not investment advice
Price data
From daily bars
Financials
Consensus estimates
The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.